SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-07-044514
Filing Date
2007-03-01
Accepted
2007-03-01 17:02:43
Documents
8
Period of Report
2006-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 1409305
2 DISCRETIONARY PERFORMANCE-BASED INCENTIVE COMPENSATION POLICY. dex1060.htm EX-10.60 19338
3 AMENDED AND RESTATED CHANGE OF CONTROL SEVERANCE BENEFIT PLAN. dex1061.htm EX-10.61 72580
4 SUBSIDIARIES OF NEKTAR THERAPEUTICS. dex211.htm EX-21.1 3417
5 CONSENT OF ERNST & YOUNG LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM. dex231.htm EX-23.1 2786
6 CERTIFICATION OF NEKTAR THERAPEUTICS' PRINCIPAL EXECUTIVE OFFICER dex311.htm EX-31.1 7310
7 CERTIFICATION OF NEKTAR THERAPEUTICS' PRINCIPAL FINANCIAL OFFICER dex312.htm EX-31.2 7397
8 SECTION 1350 CERTIFICATIONS. dex321.htm EX-32.1 4668
  Complete submission text file 0001193125-07-044514.txt   1528391
Mailing Address 150 INDUSTRIAL ROAD SAN CARLOS CA 94070
Business Address 150 INDUSTRIAL RD SAN CARLOS CA 94070 6506313100
NEKTAR THERAPEUTICS (Filer) CIK: 0000906709 (see all company filings)

IRS No.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-24006 | Film No.: 07664415
SIC: 2834 Pharmaceutical Preparations